Financing channel feed – Endpoints News

Financing channel feed

Kite partner HiFiBiO closes $67M round for preclinical antibody candidates churned out of single-cell analytics platform

6 years ago

Cowen, Perceptive lead $79.5M Series B for 'standout' biotech shepherding oncolytic virus to clinic

6 years ago

Fresh from $102M haul, IGM Bio pitches $100M IPO as it plots first-in-human trial of new antibodies

6 years ago

SpringWorks seeks $115M to push Pfizer drugs across finish line while Satsuma sells migraine play in $86M IPO

6 years ago

Healthier, longer lifespans will be a reality sooner than you think, Juvenescence promises as it closes $100M round

6 years ago

A budget biotech you likely never heard about is setting a course for Wall Street with some modest ambitions

6 years ago

Johns Hopkins scientists raise $137M megaround for a trio of spinouts looking to tackle Alzheimer’s, Parkinson’s and fibrosis

6 years ago

Biotech targeting rare heart mutation with gene therapy scores $11M in Series A haul

6 years ago

IBD startup Landos lands $60M Series B in first test case of Chris Garabedian's lean and mean model at Xontogeny

6 years ago

A top analyst spotlights a wave of biotech startups looking to catapult onto Nasdaq — or get bought out

6 years ago

Move over, Hong Kong: Shanghai’s new tech board sees fervent demand for maiden biotech IPO

6 years ago

At newly rechristened Rakuten Medical, Japanese billionaire Mikitani ups the ante with another megaround

6 years ago

Arie Belldegrun and the crew at Vida reap a $600M harvest for fund II — and they've got LA in their sights

6 years ago

Wellington Partners tanks up with $237M for its next life sci fund — same strategy, but with more cash on hand

6 years ago

Approval in sight, Perceptive, OrbiMed double down on Foamix's antibiotic foam to the tune of $64M

6 years ago

Laser-focused on colorectal cancer test, Freenome wins $160M from marquee VC pack led by RA, Polaris

6 years ago

Novartis backs Harvard spinout's quest to build TCR repository in $48M round

6 years ago

Frequency follows Astellas pact with $62M round to bankroll PhII of lead regenerative drug

6 years ago

Medicxi is rolling out its biggest fund ever to back Europe's top 'scientists with strange ideas'

6 years ago

Biotech unicorns first to go as Neil Woodford auctions assets off suspended fund — report

6 years ago

Denmark's Genmab hits the jackpot with $500M+ US IPO as smaller biotechs rake in a combined $147M

6 years ago

Backed by some of the biggest names in biotech, Norbert Bischofberger gets his megaround for platform tech out of MIT

6 years ago

Following footsteps of chart-topping Chinese counterparts, Alphamab Oncology files IPO at HKEX

6 years ago

Bayer, Longwood back star researcher's deep dive into the tumor microenvironment for new I/O targets

6 years ago

First page Previous page 109 110 111112113 114 115 Next page Last page